Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 907-605-7 | CAS number: 68815-47-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable to guideline study with acceptable restrictions (mostly due to reduced reporting in times before GLP, e.g. no single animal data presented, results of preliminary test not reported, lacking information on animal husbandry, occlusive conditions)
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- mostly due to reduced reporting in times before GLP, e.g. no single animal data presented, results of preliminary test not reported, lacking information on animal husbandry, occlusive conditions
- GLP compliance:
- no
- Remarks:
- study performed before GLP statement
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- bis(6-aminohexyl)amine; hexane-1,6-diamine
- EC Number:
- 907-605-7
- Cas Number:
- 68815-47-4
- Molecular formula:
- C6H16N2 (HMD) C12H29N3 (BHT)
- IUPAC Name:
- bis(6-aminohexyl)amine; hexane-1,6-diamine
- Details on test material:
- - Name of test material (as cited in study report): 22983 R.P. (produit technique); Bis Hexamethylene triamine, culot de distillation
- Physical state:solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Oncins, IFFA CREDO, France
- Weight at study initiation: 120-150 g
ENVIRONMENTAL CONDITIONS
no further details
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 6cm x 6cm
- Type of wrap if used: aluminium foil and adhesive tape
REMOVAL OF TEST SUBSTANCE
- Washing (if done): with lukewarm soap water
- Time after start of exposure: 24 h (directly after patch removal)
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.85 ml/kg
- Other: as the test material was solid at 24 °C as well as in between 32 and 34°C, the test material was heated to 37 °C, became fluid and was administered pure to the skin of test animals
TEST SITE
- Area of exposure:
- % coverage:
- Type of wrap if used:
REMOVAL OF TEST SUBSTANCE
- Washing (if done):
- Time after start of exposure:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution):
- Constant volume or concentration used: yes/no
- For solids, paste formed: yes/no
VEHICLE
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution):
- Lot/batch no. (if required):
- Purity: - Duration of exposure:
- 24 hours
- Doses:
- 740, 1110, 1670, and 2500 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- other: one group of vehicle treated animals were kept in order to determine normal body weight development.
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing: every 5th day (i.e. study day 0, 5, 10 and 15) for vehicle treated groups and animals treated with 740 mg/kg bw (which is the highest dose which did not produce deaths)
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight and gross pathology - Statistics:
- LD50 value was calculated using the method of Litchfield and Wilcoxon.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 500 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 160 - 1 930
- Remarks on result:
- other: Within the 14 days observation period no animals died after single application of 740 mg/kg bw. 1/10, 8/10 and 9/10 animals died using 1110, 1670 and 2500 mg/kg bw respectively. Deaths occurred within 1 to 5 days post application.
- Mortality:
- 740 mg/kg bw: 0 males and 0 females died
1110 mg/kg bw: 1/10 animals died, death occurred within 5 days after administration
1670 mg/kg bw: 8/10 animals died, death occurred within 2 to 5 days after administration
2500 mg/kg bw: 9/10 animals; death occurred 1 to 4 days after administration )
All animals that died were dead within 1 to 5 days after administration - Clinical signs:
- other: 740 and 1110 mg/kg bw: Less severe effects on motoric activity as described at the highest dose level. 1670 mg/kg bw: same symptoms as described in the high dose group with cachexia being obvious at treatment days 1 to 5 within the surviving animals. 25
- Gross pathology:
- 740 mg/kg bw: In 7 animals necrosis was obvious 7days after test item administration. In the other animals eschar formation was seen 7 days after dose administration and scarring began on day 14 after start of exposure.
1110 mg/kg bw: In 3 animals necrosis was obvious 2 hours after the patch removal. Eschar formation in the other animals started at day 7 after test item administration. Just before the end of the observation period scarring could be observed.
1670 mg/kg bw: in the surviviing animals (i.e. 2/10) beginning at three days after administration, necrosis was obvious. The edges were indured and persistet up until the end of the observation period.
2500 mg/kg bw: the only surviving animal showed induration of skin which began to recover from day 4 until the end of the observation period
Any other information on results incl. tables
Bodyweight development: Bodyweights given as group mean [g]+/- standard deviation after "n" days in observation
|
n.s. difference to control group not statistically significant
s.s. difference to control group statistically significant
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Acute toxicity category 4 Criteria used for interpretation of results: EU
- Conclusions:
- After single dermal application of either 740, 1110, 1670 or 2500 mg test substance per kg onto the skin of male and female rats lethality could be observed during the 14 day observation period, resulting in a LD50 of 1500 mg/kg bw.
- Executive summary:
Acute dermal toxicity was investigated using male and female Sprague-Dawley rats in a test similar to acute standard method (i.e. OECD TG 402, non GLP). The test substance was administered to the skin for 24 hours under occlusive conditions at doses of 740, 1110, 1670 and 2500 mg/kg bw to 4 groups of 10 animals (5animals/sex).
Clinical signs (dyspnea, agitation, apathy, atonia (with tremor and convulsions), hypothermia, cachexia) were observed starting from the mid-dose group. Within the 14 days observation period no animals died after single application of 740 mg/kg bw. 1/10, 8/10 and 9/10 animals died using 1110, 1670 and 2500 mg/kg bw respectively. Deaths occurred within 1 to 5 days post application. Having this results a median lethal dose (LD50) of 1500 mg/kg bw was identified for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
